On April 4-5, 2022, biopharma and medical device professionals responsible for clinical operations, data management and risk evaluation are invited to attend the live streaming of the 2nd Risk-Based Quality Management Summit. The event is organized by Dynamic Global Events (“DGE”), an educational conference company specializing in the informational and networking needs of the life science sector.
The 2-day event will start with the chairperson’s opening remarks followed by keynotes on a structured change management program for RBQM success. For successful risk-based monitoring and effective implementation of clinical trials, a world-class end-to-end comprehensive risk management plan is essential. The agenda goes into extensive detail on this topic.
Experts will discuss the effective methods to convince and educate shareholders on the importance of complete buy-in across the organization. They will further talk about the importance of regulatory acceptance of remote monitoring and digital technologies, and also share their expertise on how to comfortably maintain levels of risk tolerance and agility in complex clinical trials while accelerating drug development.
This summit covers new approaches in mitigating risk and managing challenges to clinical trial oversight. The RBQM Summit provides up-to-date strategies on reducing the complexity and costs associated with clinical trials, cutting down the risks involved, and deriving the maximum output from the R&D budget. Companies and professionals will learn how to evaluate risks in virtual trials, understand the complexities involved, and thereafter construct a strong framework for their clinical trials.
Industry leaders with robust experience will share insights on K-97-1 and the FDA’s “Decision Tree”. Attendees will also learn the spotlight benefits of AI and ML for curating unstructured data. They can leverage this platform to explore data literacy as the change agent to deliver study wide insights, and learn to plan and implement QTLs for ICH E6 (“R2”) compliance.
Despite all measures, why do clinical trials fail? Join the valuable sessions at the 2nd Risk-Based Quality Management Summit to understand why studies fail and build strategies to improve trial success.
To learn more, please visit https://ibn.fm/TSqRE
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.